Zacks Funding Analysis reduce shares of Aphria (NYSE:APHA) from a purchase score to a maintain score in a report issued on Tuesday morning, Zacks.com stories.
In accordance with Zacks, “Aphria Inc. produces, provides and sells medical cannabis primarily in Canada. The corporate presents sativa, indica and hybrid medical marijuana merchandise, in addition to cannabis oils. Aphria Inc. is headquartered in Leamington, Canada. “
A number of different analysis analysts have additionally issued stories on the corporate. CIBC lowered Aphria from a impartial score to a sector underperform score in a report on Friday, July 26th. ValuEngine upgraded Aphria from a maintain score to a purchase score in a report on Thursday, August 1st. One funding analyst has rated the inventory with a promote score, two have assigned a maintain score and 6 have given a purchase score to the corporate’s inventory. The corporate presently has a consensus score of Purchase and a mean worth goal of $13.29.
Shares of NYSE:APHA opened at $5.30 on Tuesday. The enterprise’s 50 day easy transferring common is $6.15 and its two-hundred day easy transferring common is $7.03. The agency has a market cap of $1.31 billion, a P/E ratio of -48.18 and a beta of two.85. Aphria has a 52-week low of $3.75 and a 52-week excessive of $16.19.
Aphria (NYSE:APHA) final introduced its quarterly earnings outcomes on Thursday, August 1st. The corporate reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.10. The agency had income of $128.60 million through the quarter, in comparison with the consensus estimate of $99.26 million. The corporate’s quarterly income was up 971.7% in comparison with the identical quarter final 12 months. On common, equities analysis analysts anticipate that Aphria will publish 0.08 earnings per share for the present 12 months.
Massive traders have just lately made adjustments to their positions within the enterprise. Synovus Monetary Corp boosted its holdings in Aphria by 56.9% within the second quarter. Synovus Monetary Corp now owns 5,514 shares of the corporate’s inventory value $39,000 after buying a further 2,000 shares within the final quarter. Capital Funding Advisory Providers LLC lifted its holdings in shares of Aphria by 2,233.3% within the second quarter. Capital Funding Advisory Providers LLC now owns 7,000 shares of the corporate’s inventory valued at $43,000 after buying a further 6,700 shares within the final quarter. Liberty Wealth Administration LLC purchased a brand new place in shares of Aphria within the second quarter valued at roughly $44,000. Tower Analysis Capital LLC TRC lifted its holdings in shares of Aphria by 76.0% within the second quarter. Tower Analysis Capital LLC TRC now owns 6,248 shares of the corporate’s inventory valued at $44,000 after buying a further 2,698 shares within the final quarter. Lastly, Advisory Providers Community LLC lifted its holdings in shares of Aphria by 45.3% within the first quarter. Advisory Providers Community LLC now owns 5,625 shares of the corporate’s inventory valued at $52,000 after buying a further 1,755 shares within the final quarter. Institutional traders and hedge funds personal 10.94% of the corporate’s inventory.
Aphria Firm Profile
Aphria Inc produces and sells medical cannabis in Canada and internationally. The corporate presents sativa, indica, and hybrid medical marijuana merchandise, in addition to cannabis oils. It serves sufferers and well being professionals. The corporate additionally sells its merchandise on-line. Aphria Inc is headquartered in Leamington, Canada.
Featured Story: Basic Evaluation
Get a free copy of the Zacks analysis report on Aphria (APHA)
For extra details about analysis choices from Zacks Funding Analysis, go to Zacks.com
Obtain Information & Rankings for Aphria Day by day – Enter your e-mail deal with under to obtain a concise each day abstract of the newest information and analysts’ rankings for Aphria and associated firms with MarketBeat.com’s FREE each day e-mail e-newsletter.